EKF Diagnostics (LON:EKF) Trading 27.3% Higher – Time to Buy?

EKF Diagnostics Holdings plc (LON:EKF) shares traded up 27.3% on Thursday . The stock traded as high as GBX 26.90 ($0.36) and last traded at GBX 25.20 ($0.33). 2,253,335 shares changed hands during mid-day trading, an increase of 353% from the average session volume of 497,132 shares. The stock had previously closed at GBX 19.80 ($0.26).

EKF Diagnostics Trading Up 3.2%

The company has a current ratio of 4.60, a quick ratio of 1.77 and a debt-to-equity ratio of 0.34. The business’s 50-day moving average is GBX 21.33 and its two-hundred day moving average is GBX 23.92. The firm has a market cap of £114.67 million, a P/E ratio of 24.01 and a beta of 0.57.

EKF Diagnostics (LON:EKF) last announced its quarterly earnings data on Tuesday, March 25th. The company reported GBX 1.38 ($0.02) earnings per share for the quarter. EKF Diagnostics had a net margin of 9.37% and a return on equity of 7.03%. As a group, analysts expect that EKF Diagnostics Holdings plc will post 2.2987842 earnings per share for the current fiscal year.

Insider Buying and Selling at EKF Diagnostics

In other news, insider Gavin T. Jones bought 50,000 shares of EKF Diagnostics stock in a transaction on Tuesday, March 25th. The stock was purchased at an average cost of GBX 22 ($0.29) per share, with a total value of £11,000 ($14,612.11). 5.24% of the stock is currently owned by company insiders.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.